← All diseases
Blood and bone marrow
Thalassemia (severe form)
Do you want to be notified if there is new research about Thalassemia (severe form)? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, above each publication you'll see one sentence explaining what was investigated — and you'll get notified as soon as there is new research on Thalassemia (severe form). View what Premium costs.
Publications and studies (1523)
- Assessment of Serum Vitamin D and Parathyroid Hormone in Children With Beta Thalassemia Major: A Case-Control Study. (2024/08/04) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Comparison of Yearly Cost Related to Complications Between Deferasirox and Deferiprone Monotherapy in Thalassemia. (2024/08/01) ♡
- Retrospective study on the distribution of hemoglobinopathies in Karnataka-A laboratory experience. (2024/07/01) ♡
- Red blood cell alloimmunization among transfusion-dependent thalassemia major patients in Northeastern Iran. (2024/07/01) ♡
- Prevalence of hemoglobinopathies using high-performance liquid chromatography as diagnostic tool in anemic patients of tertiary care center of Western India. (2024/07/01) ♡
- Correlation of Klotho Protein with Troponin-I as a Marker of Myocardial Damage in Iraqi Beta-Thalassemia Major Patients. (2024/07/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Macitentan Administration for Pulmonary Hypertension Due to β-thalassemia with Multiple Organ Failure. (2024/06/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Endocrinopathies in beta thalassemia: a narrative review. (2024/06/01) ♡
- Droplet digital polymerase chain reaction-based quantitation of therapeutic lentiviral vector copies in transduced hematopoietic stem cells. (2024/06/01) ♡
- Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. The effect of aqueous extract of Iranian oak (Quercus brantii) on antioxidant capacity and oxidative stress in beta-thalassemia patients: Randomized controlled trial. (2024/06/01) ♡
- Nutritional and Body Composition Changes in Paediatric β-Thalassemia Patients Undergoing Hematopoietic Stem Cell Transplantation: A Retrospective Study Using Bioelectrical Impedance Analysis. (2024/05/09) ♡
- Neonatal Screening for Sickle Cell Disease in Western Andalusia: Results and Lessons Learnt after 3 Years of Implementation. (2024/05/01) ♡
- Can N-acetylcysteine reduce red blood cell transfusion burden in patients with transfusion-dependent β-thalassemia? (2024/05/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Thalassemia skull. (2024/05/01) ♡
- Hematopoietic stem cell transplantation for B-thalassemia major with alemtuzumab. (2024/05/01) ♡
- Enhancing thalassemia gene carrier identification in non-anemic populations using artificial intelligence erythrocyte morphology analysis and machine learning. (2024/05/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. COMBINED CENTRAL RETINAL VASCULAR OCCLUSION AS THE PRESENTING FEATURE IN β-THALASSEMIA WITH IRON DEFICIENCY ANEMIA. (2024/05/01) ♡
- Anemia among Medical Students from Jakarta: Indonesia-Iron Deficiency or Carrier Thalassemia? (2024/04/12) ♡
- Clinical, laboratory, and molecular characteristics of a cohort of children with hemoglobinopathy S/beta-thalassemia. (2024/04/01) ♡
- Spectrum of Rare and Novel Indel Mutations Responsible for β Thalassemia in Eastern India. (2024/04/01) ♡
- Detection of 13 Novel Variants and Investigation of Mutation Distribution by Next Generation Sequencing in Hemoglobinopathies: A Single Center Experience. (2024/04/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Defining curative endpoints for transfusion-dependent β-thalassemia in the era of gene therapy and gene editing. (2024/03/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Reduction of extramedullary erythropoiesis and amelioration of anemia in a β-thalassemia patient treated with thalidomide. (2024/03/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Global distribution of β-thalassemia mutations: An update. (2024/02/20) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. A synonymous variant is unmasked in thalassaemia. (2024/02/01) ♡
- Effect of serum panel reactive antibodies on allogeneic hematopoietic stem cell transplantation in pediatric thalassemia patients: A single-center experience. (2024/02/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Unmet needs in β-thalassemia and the evolving treatment landscape. (2024/02/01) ♡
- In situ correction of various β-thalassemia mutations in human hematopoietic stem cells. (2024/01/25) ♡
- A randomized placebo-controlled clinical trial of oral green tea epigallocatechin 3-gallate on erythropoiesis and oxidative stress in transfusion-dependent β-thalassemia patients. (2024/01/24) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Beyond the promise: evaluating and mitigating off-target effects in CRISPR gene editing for safer therapeutics. (2024/01/18) ♡
- Differentinating between non-transfusion dependant β-thalassemia and iron deficinecy anemia in children using ROC and logistic regression analysis: two novel discrimination indices designed for pediatric patients. (2024/01/16) ♡
- Predictors of anaemia in mothers and children in Uttar Pradesh, India. (2024/01/08) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Multisystem inflammatory syndrome in children with COVID-19 in a multitransfused patient. (2024/01/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Clonal hematopoiesis and acquired genetic abnormalities of the red cell: An historical review. (2024/01/01) ♡
- Reducing the transcriptional read-through rate of a lentiviral vector for β-thalassemia gene therapy. (2024/01/01) ♡
- Clinical utility of circulating TWEAK and CD163 as biomarkers of iron-induced cardiac decompensation in transfusion dependent thalassemia major. (2024/01/01) ♡
- GDF15 linked to maternal risk of nausea and vomiting during pregnancy. (2024/01/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Four‑Dimensional Echocardiographic Evaluation of Cardiac Iron Overload in Patients with Beta-Thalassemia Major. (2024/01/01) ♡
- Mutation spectrum of thalassemia among pre-pregnant adults in the Jiangsu Province by capillary electrophoresis-based multiplex PCR assay. (2024/01/01) ♡
- The Prevalence of Pulmonary Arterial Hypertension in Patients with Beta Thalassemia Major. (2024/01/01) ♡
- B12 Deficiency is the Commonest Cause of Anaemia During Pregnancy in Northern India: Study from a Tertiary Care Institute. (2024/01/01) ♡
- A scoping review exploring cure definitions and language for inherited hemoglobinopathies. (2024/01/01) ♡
- The effect of blood transfusion on serum hepcidin levels in chronically transfused patients of β-thalassemia major: An observational study in a tertiary care centre in Western Maharashtra. (2024/01/01) ♡
- COMPARISON OF DIFFERENT TREATMENT MODALITIES OF CHELATION THERAPY IN BETA-THALASSEMIA MAJOR PATIENTS. (2024/01/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Clinical Study of Super Transplantation in the Treatment of Severe β-thalassemia (2024-12-16) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Safety and Efficacy Evaluation of β-globin Restored Autologous Hematopoietic Stem Cells in β-thalassemia Major Patients (2024-11-29) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. FLOWER: Following Longitudinal Outcomes With Epidemiology for Rare Diseases (2024-11-14) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. A Pilot Study on the Safety and Efficacy of YOLT-204 for Transfusion-Dependent Beta-Thalassemia (2024-11-07) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. A Post-Marketing Surveillance Study to Assess Safety of Luspatercept in Korean Patients With Myelodysplastic Syndrome or β-thalassemia (2024-11-06) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Decision-Making and Quality of Life Surrounding Hematologic Disease and Gene Therapy (2024-10-29) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.